Practice
Featured experience
Truist $15.5 billion sale of remaining stake in Truist Insurance to investor group
We are advising Truist on the transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Amer Sports $1.37 billion IPO
We advised Amer Sports on its IPO and NYSE listing
Instant Brands sale of substantially all of its assets to Centre Lane Partners
We are advising Instant Brands on the sale
Nuvei $6.3 billion going-private acquisition
We are advising Nuvei on the transaction
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
Narragansett Electric $500 million senior notes offering
We advised the company on the transaction
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Reddit $748 million IPO
The shares are listed on the New York Stock Exchange
REV Group $127.5 million secondary offering
We advised REV Group on its SEC-registered secondary stock offering
Trial Holdings ¥44.6 billion IPO
The shares are listed on the Tokyo Stock Exchange
Crane NXT $270 million acquisition of OpSec Security
We are advising Crane NXT on the acquisition
Rubicon closes approximately $1.18B fundraise for second flagship PE fund
We advised Rubicon on the fundraise
SMFG $1 billion perpetual subordinated notes offering
We advised SMFG on its SEC-registered offering of Additional Tier 1 notes